Inflammatory gene expression associates with hepatitis B virus cccDNA- but not integrant-derived transcripts in HBeAg negative disease

Inflammatory gene expression associates with hepatitis B virus cccDNA- but not integrant-derived transcripts in HBeAg negative disease

Chronic hepatitis B virus (HBV) infection is a global health problem that presents as a spectrum of liver disease, reflecting an interplay between the virus and the host immune system. HBV genomes exist as episomal covalently closed circular DNA (cccDNA) or chromosomal integrants. The relative contr...

Bibliografiset tiedot
Päätekijät:	Magri, A, Harris, JM, D'Arienzo, V, Minisini, R, Jühling, F, Wing, PAC, Rapetti, R, Leutner, M, Testoni, B, Baumert, TF, Zoulim, F, Balfe, P, Pirisi, M, McKeating, JA
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	MDPI 2022

Samankaltaisia teoksia

Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease
Tekijä: Andrea Magri, et al.
Julkaistu: (2022-05-01)

Gene Editing Technologies to Target HBV cccDNA
Tekijä: Maria Guadalupe Martinez, et al.
Julkaistu: (2022-11-01)

CTCF regulates hepatitis B virus cccDNA chromatin topology
Tekijä: Dobrica, MO, et al.
Julkaistu: (2023)

CTCF regulates hepatitis B virus cccDNA chromatin topology
Tekijä: Dobrica, MO, et al.
Julkaistu: (2024)

A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis
Tekijä: Wing, P, et al.
Julkaistu: (2019)

Estimation of hepatitis B virus cccDNA persistence in chronic infection using within-host evolutionary rates
Tekijä: Lythgoe, KA, et al.
Julkaistu: (2020)

Mechanism of Hepatitis B Virus cccDNA Formation
Tekijä: Lei Wei, et al.
Julkaistu: (2021-07-01)

Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α
Tekijä: Kaimin Song, et al.
Julkaistu: (2025-02-01)

Is the function of the HBeAg really unknown?
Tekijä: David R. Milich
Julkaistu: (2019-09-01)

Mathematical investigation of HBeAg seroclearance
Tekijä: Sarah Kadelka, et al.
Julkaistu: (2019-08-01)

Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels
Tekijä: Ko, C, et al.
Julkaistu: (2018)

Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B.
Tekijä: Thilde Nordmann Winther, et al.
Julkaistu: (2013-01-01)

HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients
Tekijä: Guangjun Song, et al.
Julkaistu: (2023-11-01)

Manifestations of perihepatic lymph nodes in acute flare of chronic hepatitis B: association with HBeAg status and with HBeAg seroconversion.
Tekijä: Yen-Ling Ko, et al.
Julkaistu: (2015-01-01)

Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks
Tekijä: Xiaomei Wang, et al.
Julkaistu: (2020-10-01)

Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus.
Tekijä: Kouichi Kitamura, et al.
Julkaistu: (2018-06-01)

Asiatic acid inhibits HBV cccDNA transcription by promoting HBx degradation
Tekijä: Ranran Li, et al.
Julkaistu: (2024-10-01)

Overexpression of DNA-methyltransferases in persistency of cccDNA pool in chronic hepatitis B
Tekijä: D S Kostyushev, et al.
Julkaistu: (2017-11-01)

A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues
Tekijä: Yan Gu, et al.
Julkaistu: (2024-01-01)

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
Tekijä: Cheng-Yuan Peng, et al.
Julkaistu: (2015-04-01)

cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B
Tekijä: Patricia Gita Naully, et al.
Julkaistu: (2025-01-01)

Mechanisms of Hepatitis B Virus cccDNA and Minichromosome Formation and HBV Gene Transcription
Tekijä: Andoni Gómez-Moreno, et al.
Julkaistu: (2024-04-01)

Super-Resolution Microscopy Analysis of Hepatitis B Viral cccDNA and Host Factors
Tekijä: Phuong Thi Bich Doan, et al.
Julkaistu: (2023-05-01)

Lamivudine therapy in HBeAg negative chronic hepatitis B patients
Tekijä: E. Guclu, et al.
Julkaistu: (2014-04-01)

HBeAg negative chronic hepatitis B in South Asia
Tekijä: Ananta Shrestha, et al.
Julkaistu: (2016-11-01)

Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markers
Tekijä: Kim, KS, et al.
Julkaistu: (2025)

HBV cccDNA: The Molecular Reservoir of Hepatitis B Persistence and Challenges to Achieve Viral Eradication
Tekijä: André Boonstra, et al.
Julkaistu: (2025-01-01)

Targeting HBV cccDNA Levels: Key to Achieving Complete Cure of Chronic Hepatitis B
Tekijä: Wei He, et al.
Julkaistu: (2024-12-01)

IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome.
Tekijä: Gianna Aurora Palumbo, et al.
Julkaistu: (2015-01-01)

Hepatitis B virus cccDNA is formed through distinct repair processes of each strand
Tekijä: Lei Wei, et al.
Julkaistu: (2021-03-01)

Envelope antibody HBeIgG and HBV DNA in HBeAg-seronegative young adults in Nigeria
Tekijä: Mathew Folaranmi Olaniyan, et al.
Julkaistu: (2023-09-01)

Circadian control of hepatitis B virus replication
Tekijä: Zhuang, X, et al.
Julkaistu: (2021)

A PCR assay to quantify patterns of HBV transcription
Tekijä: D'Arienzo, V, et al.
Julkaistu: (2019)

DNA Sensor ABCF1 Phase Separates With cccDNA to Inhibit Hepatitis B Virus Replication
Tekijä: Caiyue Ren, et al.
Julkaistu: (2024-12-01)

Early Steps of Hepatitis B Life Cycle: From Capsid Nuclear Import to cccDNA Formation
Tekijä: João Diogo Dias, et al.
Julkaistu: (2021-04-01)

cccDNA-Targeted Drug Screen Reveals a Class of Antihistamines as Suppressors of HBV Genome Levels
Tekijä: Ee Chee Ren, et al.
Julkaistu: (2023-09-01)

Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP‐Based Therapy
Tekijä: Michel Bazinet, et al.
Julkaistu: (2021-11-01)

Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx–DDB1 InteractionSummary
Tekijä: Kazuma Sekiba, et al.
Julkaistu: (2019-01-01)

Correction: IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome.
Tekijä: Gianna Aurora Palumbo, et al.
Julkaistu: (2015-01-01)

Baseline value of intrahepatic HBV DNA over cccDNA predicts patient’s response to interferon therapy
Tekijä: Di Mu, et al.
Julkaistu: (2017-07-01)